Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3) Antibody

Este producto es parte de AKR7 - Aflatoxin B1 aldehyde reductase member
Product Graph
364€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx230267
tested applications
ELISA, WB

Description

AKR7A3 Antibody is a Rabbit Polyclonal against AKR7A3.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/500 - 1/5000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
≥ 95% (SDS-PAGE)
Purification
Purified by immunogen affinity chromatography.
Size 1
100 µg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O95154
Gene ID
22977
OMIM
608477
Alias
AKR7A3,AFAR2
Background
Antibody anti-AKR7A3
Status
RUO
Note
Concentration: 2 mg/ml - Validity: 12 months.

Descripción

AKR7A3 shares significant structural and functional similarity with AKR7A2 and is involved in detoxifying aflatoxin B1-derived reactive aldehydes and other toxic carbonyl compounds. It functions as a critical enzyme in aldehyde metabolism, protecting cells from the damaging effects of reactive aldehydes produced during oxidative stress, lipid peroxidation, and xenobiotic metabolism. AKR7A3 is expressed in the liver and gastrointestinal tissues, where it contributes to the defense against dietary toxins, including aflatoxins and other environmental carcinogens. Its ability to detoxify lipid peroxidation products like 4-HNE and malondialdehyde highlights its role in preventing oxidative stress-related cellular damage and carcinogenesis. AKR7A3 also plays a role in maintaining liver homeostasis and mitigating toxin-induced liver injury. Dysregulation or reduced expression of AKR7A3 can increase susceptibility to liver cancer and chronic liver diseases by promoting the accumulation of reactive aldehydes and subsequent DNA damage. Emerging research focuses on its potential as a biomarker for toxin exposure and a target for improving antioxidant defenses in liver-related disorders.

Related Products

FNab00267

AKR7A3 antibody

Can reduce the dialdehyde protein-binding form of aflatoxin B1(AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.

Ver Producto
P4305

Recombinant Human AKR7A3

Ver Producto
abx005728

Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3) Antibody

AKR7A3 Antibody is a Rabbit Polyclonal Antibody against AKR7A3.

Ver Producto